RHUMBLINE ADVISERS - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$485
-99.9%
22,452
+5.4%
0.00%0.0%
Q3 2022$412,000
+4.3%
21,297
+7.2%
0.00%0.0%
Q2 2022$395,000
-26.3%
19,873
+10.6%
0.00%0.0%
Q1 2022$536,000
+29.8%
17,970
+1.2%
0.00%0.0%
Q4 2021$413,000
-26.6%
17,754
-1.7%
0.00%0.0%
Q3 2021$563,000
-8.3%
18,060
+3.4%
0.00%0.0%
Q2 2021$614,000
-7.3%
17,459
-7.0%
0.00%0.0%
Q1 2021$662,000
-10.5%
18,766
-4.9%
0.00%0.0%
Q4 2020$740,000
+38.8%
19,736
+23.5%
0.00%0.0%
Q3 2020$533,000
+16.6%
15,979
-7.3%
0.00%0.0%
Q2 2020$457,000
+102.2%
17,242
+25.0%
0.00%
Q1 2020$226,000
-32.9%
13,797
+4.2%
0.00%
-100.0%
Q4 2019$337,000
+28.1%
13,242
+0.7%
0.00%
Q3 2019$263,000
-37.5%
13,150
+0.8%
0.00%
-100.0%
Q2 2019$421,000
+1.2%
13,050
+1.1%
0.00%0.0%
Q1 2019$416,000
+30.0%
12,906
-1.1%
0.00%0.0%
Q4 2018$320,000
+4.2%
13,056
+40.2%
0.00%0.0%
Q3 2018$307,000
-8.4%
9,313
-1.3%
0.00%0.0%
Q2 2018$335,0009,4380.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Prosight Management, LP 514,082$11,973,0007.17%
Privium Fund Management B.V. 379,117$8,959,0001.78%
Birchview Capital, LP 113,000$2,632,0001.70%
Sio Capital Management, LLC 213,913$4,982,0001.50%
Perceptive Advisors 4,720,278$109,936,0000.85%
Chicago Capital, LLC 849,239$19,779,0000.74%
APOGEM CAPITAL LLC 38,601$899,0000.59%
Samsara BioCapital, LLC 100,000$2,329,0000.45%
Artal Group S.A. 600,000$13,974,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 458,011$10,667,0000.38%
View complete list of ALBIREO PHARMA INC shareholders